<DOC>
	<DOCNO>NCT01302366</DOCNO>
	<brief_summary>This study propose determine clinical activity agent patient asymptomatic multiple myeloma . It believe TBL12 help delay onset active multiple myeloma , few-if any- side effect .</brief_summary>
	<brief_title>A Trial TBL12 Sea Cucumber Extract Patients With Untreated Asymptomatic Myeloma</brief_title>
	<detailed_description>Multiple myeloma cancer evolve state know Monoclonal Gammopathy Undetermined Significance ( MGUS ) , define parameter M spike bone marrow . After evolution myeloma , patient may asymptomatic , , without endorgan disease hypercalcemia , renal insufficiency , anemia bone lesion . In asymptomatic myeloma ( ASxM ) , standard therapy . Thalidomide try patient ASxM significant toxicity . The patient ASxM evaluable term paraprotein measurement . TBL12 sea cucumber extract show number antitumor property preclinically , include antiangiogenesis direct tumor cytotoxicity . TBL12 use number patient food supplement without toxicity detect . The investigator thus propose determine clinical activity agent patient ASxM . Patients give TBL12 dose 2 unit 20 mL twice per day daily disease progression effect paraprotein note . Clinical effect see correlate vitro change angiogenesis patient bone marrow sample . The result trial may form basis use nontoxic agent patient prodrome early cancer .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<criteria>Diagnosis multiple myeloma base standard criterion follow : Major Criteria Plasmacytomas tissue biopsy Bone marrow plasmacytosis ( &gt; 30 % plasma cell ) Monoclonal immunoglobulin ( Ig ) spike serum electrophoresis ( IgG &gt; 3.5 g/dL IgA &gt; 2.0 g/dL ) ; kappa lambda light chain excretion &gt; 1 g/day 24 hour urine protein electrophoresis Minor Criteria Bone marrow plasmacytosis ( 10 30 % plasma cell ) Monoclonal immunoglobulin present less magnitude give major criterion Normal IgM &lt; 50 mg/dL , IgA &lt; 100 mg/dL , IgG &lt; 600 mg/dL Any follow set criterion confirm diagnosis Multiple Myeloma : Any two major criterion Major criterion 1 plus minor criterion b , c Major criterion 3 plus minor criterion c Minor criterion , b c Measurable disease , define monoclonal immunoglobulin spike serum electrophoresis ≥ 1 g/dL and/or urine monoclonal immunoglobulin spike ≥ 200 mg/24 hour . Nonsecretors must measurable protein Freelite measurable disease plasmacytoma eligible . Has asymptomatic disease , i.e. , hypercalcemia , renal insufficiency , anemia bone lesion . Karnofsky performance status ≥ 80 ( See Appendix B ) Is infertile ( i.e . surgically sterile 12 month postmenopausal ) practice adequate form contraception , judge investigator ( i.e. , birth control pill , double barrier method , abstinence , etc . ) Age 18 year old Has give voluntary write informed consent , prior studyrelated procedure part normal medical care , understand patient may withdraw consent time without prejudice future medical care . Prior treatment myeloma ( symptomatic asymptomatic ) . POEMS syndrome ( plasma cell dyscrasia polyneuropathy , organomegaly , endocrinopathy , monoclonal protein ( Mprotein ) skin change ) Plasma cell leukemia Patients history thyroid problem . Receiving steroid &gt; equivalent 10 mg prednisone daily medical condition , e.g. , asthma , systemic lupus erythematosis , rheumatoid arthritis Infection control antibiotic Human Immunodeficiency Virus ( HIV ) infection . Patients provide consent HIV test accord institution 's standard practice Known active hepatitis B C New York Hospital Association ( NYHA ) Class III IV heart failure EKG evidence acute ischemic disease Second malignancy require treatment last 3 year Other serious medical psychiatric illness could potentially interfere completion treatment accord protocol Positive pregnancy test woman childbearing potential</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>multiple myeloma</keyword>
	<keyword>myeloma</keyword>
	<keyword>asymptomatic myeloma</keyword>
	<keyword>smolder myeloma</keyword>
	<keyword>Asymptomatic ( smolder ) myeloma</keyword>
</DOC>